Impact of metformin use on neurocognitive functions in older people: a systematic review and meta-analysis

Metformin is a widely prescribed drug for managing diabetes mellitus. Recent studies have investigated its potential effects on cognitive function in adults aged 60 years and older, a population that is steadily increasing and often exhibits cognitive impairments associated with aging and other chronic conditions.

Objective

This study aimed to evaluate the impact of metformin use on cognitive functions in older adults through a meta-analysis.